603456 九洲药业
已收盘 09-01 15:00:00
资讯
新帖
简况
9月1日九洲药业涨5.75%，京管泰富科技驱动混合A基金重仓该股
证券之星 · 08:20
9月1日九洲药业涨5.75%，京管泰富科技驱动混合A基金重仓该股
九洲药业涨5.75%，长城国瑞证券二周前给出“买入”评级
证券之星 · 08:20
九洲药业涨5.75%，长城国瑞证券二周前给出“买入”评级
九洲药业股价微跌0.86% 葛兰旗下基金二季度减持438万股
金融界 · 08-21
九洲药业股价微跌0.86% 葛兰旗下基金二季度减持438万股
每周股票复盘：九洲药业（603456）子公司通过美国FDA现场检查
证券之星 · 08-16
每周股票复盘：九洲药业（603456）子公司通过美国FDA现场检查
九洲药业(603456.SH)子公司瑞博苏州通过美国FDA现场检查
智通财经 · 08-12
九洲药业(603456.SH)子公司瑞博苏州通过美国FDA现场检查
数字人浙小景播报：九洲药业受机构券商关注最高
全景网 · 08-11
数字人浙小景播报：九洲药业受机构券商关注最高
九洲药业、比亚迪等目标价涨幅超50%；6家公司评级被调低丨券商评级观察
21世纪经济报道 · 08-11
九洲药业、比亚迪等目标价涨幅超50%；6家公司评级被调低丨券商评级观察
信达证券：九洲药业DMO业务保持高增长，新分子业务布局有望打造全新增长点
瑞财经 · 08-08
信达证券：九洲药业DMO业务保持高增长，新分子业务布局有望打造全新增长点
28股获券商买入评级，九洲药业目标涨幅达57.75%
第一财经 · 08-07
28股获券商买入评级，九洲药业目标涨幅达57.75%
九洲药业上半年净利增11%，董事长花莉蓉年薪198万元、曾入选“台州女首富”
瑞财经 · 08-06
九洲药业上半年净利增11%，董事长花莉蓉年薪198万元、曾入选“台州女首富”
社保基金现身3只个股前十大流通股东，合计持股市值达2.82亿元
第一财经 · 08-06
社保基金现身3只个股前十大流通股东，合计持股市值达2.82亿元
半年报汇总丨这家公司上半年净利润同比增近60%
第一财经 · 08-05
半年报汇总丨这家公司上半年净利润同比增近60%
九洲药业：审议通过2025年半年度报告及利润分配等议案
公司公告 · 08-05
九洲药业：审议通过2025年半年度报告及利润分配等议案
九洲药业增资2亿元支持CDMO生产基地建设
财中社 · 08-05
九洲药业增资2亿元支持CDMO生产基地建设
九洲药业(603456.SH)发布上半年业绩，归母净利润5.26亿元，增长10.70%
智通财经 · 08-05
九洲药业(603456.SH)发布上半年业绩，归母净利润5.26亿元，增长10.70%
九洲药业：上半年净利5.26亿元，同比增10.70%
格隆汇 · 08-05
九洲药业：上半年净利5.26亿元，同比增10.70%
九洲药业拟8月11日召开2025年半年度业绩说明会
格隆汇 · 08-03
九洲药业拟8月11日召开2025年半年度业绩说明会
每周股票复盘：九洲药业（603456）使用7.85亿元闲置募集资金购买银行存单
证券之星 · 08-02
每周股票复盘：九洲药业（603456）使用7.85亿元闲置募集资金购买银行存单
九洲药业：公司CDMO项目主要涉及抗感染、中枢神经、抗肿瘤、抗心衰、抗病毒等治疗领域
互动易 · 08-01
九洲药业：公司CDMO项目主要涉及抗感染、中枢神经、抗肿瘤、抗心衰、抗病毒等治疗领域
医药研发外包CRO，谁是盈利最强企业？
Ofweek维科网 · 07-30
医药研发外包CRO，谁是盈利最强企业？
加载更多
公司概况
公司名称：
浙江九洲药业股份有限公司
所属行业：
医药制造业
上市日期：
2014-10-10
主营业务：
浙江九洲药业股份有限公司的主营业务是为全球制药公司、生物科技公司、科研机构等提供一站式的医药定制研发和生产（CDMO）服务。公司的主要产品是小分子化学药物、多肽药物、偶联药物和小核酸药物。公司荣获2025中国医药CDMO企业20强、2024年度中国医药工业主营业务收入前100位企业、2024年EcoVadis企业社会责任评级“金牌”认证、全球优选合作伙伴奖、ESG责任企业奖等多项荣誉。
发行价格：
15.43
{"stockData":{"symbol":"603456","market":"SH","secType":"STK","nameCN":"九洲药业","latestPrice":19.13,"timestamp":1756710000000,"preClose":18.09,"halted":0,"volume":48231900,"delay":0,"changeRate":0.0575,"floatShares":889000000,"shares":889000000,"eps":0.7386,"marketStatus":"已收盘","change":1.04,"latestTime":"09-01 15:00:00","open":18.15,"high":19.26,"low":18,"amount":902000000,"amplitude":0.0697,"askPrice":19.13,"askSize":2392,"bidPrice":19.12,"bidSize":540,"shortable":0,"etf":0,"ttmEps":0.7386,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756776600000},"marketStatusCode":5,"adr":0,"adjPreClose":18.09,"symbolType":"stock","openAndCloseTimeList":[[1756690200000,1756697400000],[1756702800000,1756710000000]],"highLimit":19.9,"lowLimit":16.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":889446028,"isCdr":false,"pbRate":1.95,"roa":"--","peRate":25.900352,"roe":"6.02%","epsLYR":0.68,"committee":-0.668514,"marketValue":17015000000,"turnoverRate":0.0542,"status":0,"floatMarketCap":17015000000},"requestUrl":"/m/hq/s/603456","defaultTab":"news","newsList":[{"id":"2564897280","title":"9月1日九洲药业涨5.75%，京管泰富科技驱动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564897280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564897280?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:20","pubTimestamp":1756714837,"startTime":"0","endTime":"0","summary":"证券之星消息，9月1日九洲药业涨5.75%，收盘报19.13元，换手率5.42%，成交量48.23万手，成交额9.02亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为北京京管泰富基金的京管泰富科技驱动混合A。京管泰富科技驱动混合A目前规模为0.57亿元，最新净值1.4961，较上一交易日下跌0.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100021062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2564897455","title":"九洲药业涨5.75%，长城国瑞证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2564897455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564897455?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:20","pubTimestamp":1756714827,"startTime":"0","endTime":"0","summary":"今日九洲药业涨5.75%，收盘报19.13元。2025年8月12日，长城国瑞证券研究员胡晨曦,魏钰琪发布了对九洲药业的研报《经营业绩修复向好，CDMO业务稳健增长》，该研报对九洲药业给出“买入”评级。考虑CDMO业务各阶段项目增长良好，部分商业化大品种受益于终端市场放量、销量持续增长，TIDES事业部及相关技术平台快速发展，公司未来有望保持增长态势；我们维持其“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100021058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","161027"],"gpt_icon":0},{"id":"2561494604","title":"九洲药业股价微跌0.86% 葛兰旗下基金二季度减持438万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2561494604","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561494604?lang=zh_cn&edition=full","pubTime":"2025-08-21 23:41","pubTimestamp":1755790909,"startTime":"0","endTime":"0","summary":"截至2025年8月21日收盘，九洲药业股价报18.43元，较前一交易日下跌0.16元，跌幅0.86%。当日成交量为254225手，成交金额达4.68亿元。九洲药业是一家专注于化学制药领域的医药企业，主要从事原料药及中间体的研发、生产和销售。公开信息显示，中欧医疗健康基金在2025年二季度对九洲药业进行了减持操作，持股数量减少438.84万股。从资金流向来看，8月21日九洲药业主力资金净流出8327.52万元，近五个交易日累计净流出2亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21234152598421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2560250179","title":"每周股票复盘：九洲药业（603456）子公司通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2560250179","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560250179?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:37","pubTimestamp":1755376629,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，九洲药业报收于18.78元，较上周的18.17元上涨3.36%。本周关注点瑞博（苏州）制药有限公司通过美国FDA cGMP现场检查，检查结果为NAI。公司公告汇总浙江九洲药业股份有限公司子公司瑞博（苏州）制药有限公司于2025年5月19日至2025年5月22日期间接受了美国食品药品监督管理局的cGMP现场检查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2558614991","title":"九洲药业(603456.SH)子公司瑞博苏州通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2558614991","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558614991?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:37","pubTimestamp":1754984242,"startTime":"0","endTime":"0","summary":"近日，瑞博苏州收到美国FDA签发的现场检查报告，该报告表明瑞博苏州已通过本次cGMP现场检查。本次通过美国FDA现场检查，表明瑞博苏州在药品cGMP质量管理体系和生产环境设施等方面符合美国FDA要求，为公司持续拓展国际市场提供了坚实的保障，并对拓展全球规范市场带来积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九洲药业(603456.SH)子公司瑞博苏州通过美国FDA现场检查","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2558387638","title":"数字人浙小景播报：九洲药业受机构券商关注最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2558387638","media":"全景网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558387638?lang=zh_cn&edition=full","pubTime":"2025-08-11 09:25","pubTimestamp":1754875542,"startTime":"0","endTime":"0","summary":"投教小课堂主板上市公司强制退市后，投资者是否还能转让股票？主板上市公司应当在深交所作出终止其股票上市决定后立即安排股票转入全国中小企业股份转让系统等证券交易场所转让的相关事宜，保证公司股票在摘牌之日起四十五个交易日内可以转让。下期“投教小课堂”与你不见不散。全景网浙江投资者教育基地秉承“沟通创造价值”宗旨，以投资者关系互动为核心，聚焦金融信息资讯服务，通过融媒体的方式，积极探索“互联网+投教”模式，以“线上+线下”相结合的方式，让投资者教育服务触手可及。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811093725a480e591&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811093725a480e591&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2558842680","title":"九洲药业、比亚迪等目标价涨幅超50%；6家公司评级被调低丨券商评级观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2558842680","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558842680?lang=zh_cn&edition=full","pubTime":"2025-08-11 09:03","pubTimestamp":1754874180,"startTime":"0","endTime":"0","summary":"南方财经8月11日电，南财投研通数据显示，8月4日至8月8日，券商给予上市公司目标价共119次，按最新收盘价计算，目标价涨幅排名居前的公司有九洲药业、比亚迪，目标价涨幅分别为60.26%、55.20%。评级调低方面，8月4日至8月8日，券商调低上市公司评级达到6家次，最新数据包括了光大证券对容百科技的评级从“买入”调低至“增持”，东方证券对涪陵榨菜的评级从“买入”调低至“增持”，平安证券对中国银行的评级从“强烈推荐”调低至“推荐”。查看原文：九洲药业、比亚迪等目标价涨幅超50%；6家公司评级被调低丨券商评级观察刚刚","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811090419a480d460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811090419a480d460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688005","03988","002594","601988","603456"],"gpt_icon":0},{"id":"2557529125","title":"信达证券：九洲药业DMO业务保持高增长，新分子业务布局有望打造全新增长点","url":"https://stock-news.laohu8.com/highlight/detail?id=2557529125","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557529125?lang=zh_cn&edition=full","pubTime":"2025-08-08 19:06","pubTimestamp":1754651205,"startTime":"0","endTime":"0","summary":"瑞财经 严明会近日，信达证券研报指出，九洲药业DMO业务保持高增长，新分子业务布局有望打造全新增长点。另外，公司全面布局多肽、偶联及小核酸药物等新分子业务，已搭建完整技术平台，2025年H1新分子业务引入新客户20多家，其中海外订单增速较快，已完成十多个项目的交付工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808190652973ba525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808190652973ba525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0276","601059","603456","BK0239"],"gpt_icon":0},{"id":"2557586761","title":"28股获券商买入评级，九洲药业目标涨幅达57.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557586761","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557586761?lang=zh_cn&edition=full","pubTime":"2025-08-07 08:33","pubTimestamp":1754526793,"startTime":"0","endTime":"0","summary":"Wind数据显示，8月6日，共有28只个股获券商买入评级，其中7只个股公布了目标价格。按最高目标价计算，九洲药业、天坛生物、中宠股份目标涨幅排名居前，涨幅分别达57.75%、55.87%、20.65%。从评级调整方向来看，20只个股评级维持不变，8只个股为首次评级。此外，有2只个股获多家券商关注，中宠股份、浦发银行获评级数量居前，分别有4家、3家券商给予评级。从获买入评级个股所属Wind行业来看，食品、饮料与烟草、材料Ⅱ、银行买入评级个股数量最多，分别有4只、3只、3只。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807083313a4799fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807083313a4799fac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600161","603456","600000"],"gpt_icon":0},{"id":"2557306559","title":"九洲药业上半年净利增11%，董事长花莉蓉年薪198万元、曾入选“台州女首富”","url":"https://stock-news.laohu8.com/highlight/detail?id=2557306559","media":"瑞财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557306559?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:54","pubTimestamp":1754495683,"startTime":"0","endTime":"0","summary":"九洲药业2025上半年公司营业收入为28.7亿元，同比上升3.9%；归母净利润为5.26亿元，同比上升10.7%；扣非归母净利润为5.26亿元，同比上升12.4%；基本每股收益 0.59 元，同比增长 11.32%。九洲药业2025年上半年经营现金流净额为8.45亿元，同比增长164.5%；EPS为0.5912元。据东方财富网数据，九洲药业董事长花莉蓉2024年所获薪酬为198.2万元。据媒体公开报道，2022年，54岁的花莉蓉以200.2亿元财富位列《2022新财富500富人榜》第236位，高居浙江台州地区第一位，被誉为浙江“台州女首富”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080623545294d3b31c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080623545294d3b31c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2557903349","title":"社保基金现身3只个股前十大流通股东，合计持股市值达2.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557903349","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557903349?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:02","pubTimestamp":1754442134,"startTime":"0","endTime":"0","summary":"具体来看，九洲药业、长虹华意、思维列控持股数量分别为0.10亿股、0.08亿股、0.03亿股，持股市值分别为1.50亿元、0.58亿元、0.74亿元。截至8月6日，社保基金二季度共现身18只个股前十大流通股东，合计持股1.96亿股，合计持股市值达45.52亿元。从持股市值来看，截至8月6日，12只个股持股市值超亿元，海大集团、藏格矿业、海信家电持股市值居前，分别为12.32亿元、7.73亿元、4.60亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806090252a4778210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806090252a4778210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603508","603456","BK0279","BK0002","BK0201"],"gpt_icon":0},{"id":"2557394240","title":"半年报汇总丨这家公司上半年净利润同比增近60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394240","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557394240?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:15","pubTimestamp":1754399756,"startTime":"0","endTime":"0","summary":"思维列控：上半年净利润3.04亿元，同比增长59.76%中宠股份：上半年净利润2.03亿元，同比增长42.56%海光信息：上半年净利润12.01亿元，同比增长40.78%东睦股份：上半年净利润2.61亿元，同比增长37.61%纽威股份：上半年净利润6.37亿元，同比增长30.47%中科曙光：上半年净利润7.31亿元，同比增长29.89%金奥博：上半年净利润8672.50万元，同比增长20.91%创","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805211556a6d49728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805211556a6d49728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603508","603019","688041","600114","603456","603699","00669"],"gpt_icon":0},{"id":"2557393551","title":"九洲药业：审议通过2025年半年度报告及利润分配等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2557393551","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557393551?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:50","pubTimestamp":1754383840,"startTime":"0","endTime":"0","summary":"九洲药业公告，第八届董事会第十六次会议于2025年8月5日召开，审议通过了包括2025年半年度报告、半年度利润分配方案、募集资金存放与使用情况专项报告等多项议案，所有议案均获全票通过。会议合法有效，符合《公司法》和《公司章程》规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165903a6d42641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165903a6d42641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2557367071","title":"九洲药业增资2亿元支持CDMO生产基地建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2557367071","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557367071?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:19","pubTimestamp":1754381988,"startTime":"0","endTime":"0","summary":"8月5日，九洲药业发布公告，决定使用部分募集资金向九洲药业（台州）有限公司增资2亿元，用于其创新药CDMO生产基地建设项目的一期工程。此次增资已经公司董事会及监事会审议通过，增资后九洲药业（台州）的注册资本将由1.75亿元增至1.9亿元，增资股本溢价1.85亿元计入资本公积。2025年一季度，九洲药业实现收入14.90亿元，归母净利润2.50亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080516244194d0ccc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080516244194d0ccc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2557736650","title":"九洲药业(603456.SH)发布上半年业绩，归母净利润5.26亿元，增长10.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557736650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557736650?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:13","pubTimestamp":1754381624,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九洲药业(603456.SH)发布2025年半年度报告，该公司营业收入为28.71亿元，同比增长3.86%。归属于上市公司股东的净利润为5.26亿元，同比增长10.70%。归属于上市公司股东的扣除非经常性损益的净利润为5.26亿元，同比增长12.40%。基本每股收益为0.59元。此外，拟向全体股东每10股派发现金股利2.00元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603456"],"gpt_icon":0},{"id":"2557366779","title":"九洲药业：上半年净利5.26亿元，同比增10.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557366779","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557366779?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:13","pubTimestamp":1754381615,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2556226822","title":"九洲药业拟8月11日召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2556226822","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556226822?lang=zh_cn&edition=full","pubTime":"2025-08-03 16:02","pubTimestamp":1754208134,"startTime":"0","endTime":"0","summary":"为便于广大投资者更全面、深入地了解公司业绩和经营情况，公司计划于2025年8月11日(星期一)15:00-16:00召开2025年半年度业绩说明会。公司将针对2025年半年度业绩、经营情况与投资者进行充分交流，在信息披露允许的范围内就投资者普遍关注的公司经营业绩、战略规划、财务状况、利润分配等问题进行回答，欢迎广大投资者积极参与。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803161558973040f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803161558973040f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2556826623","title":"每周股票复盘：九洲药业（603456）使用7.85亿元闲置募集资金购买银行存单","url":"https://stock-news.laohu8.com/highlight/detail?id=2556826623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556826623?lang=zh_cn&edition=full","pubTime":"2025-08-03 01:11","pubTimestamp":1754154672,"startTime":"0","endTime":"0","summary":"截至2025年8月1日收盘，九洲药业报收于18.32元，较上周的17.22元上涨6.39%。本周，九洲药业7月30日盘中最高价报19.98元，股价触及近一年最高点。本周关注点公司公告汇总：九洲药业使用7.85亿元闲置募集资金购买银行存单，期限分别为3个月、6个月和12个月公司公告汇总浙江九洲药业股份有限公司关于开立募集资金现金管理产品专用结算账户及使用闲置募集资金进行现金管理的进展公告。浙江九洲药业股份有限公司董事会2025年7月30日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080300000052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","161121","BK0239"],"gpt_icon":0},{"id":"2556892077","title":"九洲药业：公司CDMO项目主要涉及抗感染、中枢神经、抗肿瘤、抗心衰、抗病毒等治疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2556892077","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556892077?lang=zh_cn&edition=full","pubTime":"2025-08-01 18:00","pubTimestamp":1754042402,"startTime":"0","endTime":"0","summary":"有投资者向九洲药业提问， 贵公司是否涉及抗生素相关业务？如果是，为何未见在年报和ESG报告中披露抗生素管理相关信息，后续是否有计划在年报及ESG报告中披露具体的抗生素管理风险与机遇？公司回答表示，您好，感谢您对公司的关注与支持，公司CDMO项目主要涉及抗感染、中枢神经、抗肿瘤、抗心衰、抗病毒等治疗领域，具体详见公司在上海证券交易所网站披露的公告，谢谢！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182545a6cd9acd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801182545a6cd9acd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0239","BK0070"],"gpt_icon":0},{"id":"2555962600","title":"医药研发外包CRO，谁是盈利最强企业？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555962600","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555962600?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:59","pubTimestamp":1753844349,"startTime":"0","endTime":"0","summary":"CRO又称“医药研发外包企业”，是指通过合同形式为医药企业在药物研发过程中提供专业化外包服务的公司或机构。医药研发外包CRO产业链企业盈利能力企业盈利能力通常表现为一定时期内企业收益数额的多少及其水平的高低。本文为企业价值系列之篇，共选取48家医药研发外包CRO产业链企业作为研究样本，并以净资产收益率、毛利率、净利率等为评价指标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","688131","603259","BK0216","02359","03759","159938","688117","603456","688621"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1756762306273,"stockEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0442},{"period":"3month","weight":0.277},{"period":"6month","weight":0.4242},{"period":"1year","weight":0.5363},{"period":"ytd","weight":0.4273}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.1528},{"period":"6month","weight":0.1597},{"period":"1year","weight":0.3636},{"period":"ytd","weight":0.1563}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江九洲药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"53672人(较上一季度减少0.57%)","perCapita":"16571股","listingDate":"2014-10-10","address":"浙江省台州市椒江区外沙路99号","registeredCapital":"88944万元","survey":" 浙江九洲药业股份有限公司的主营业务是为全球制药公司、生物科技公司、科研机构等提供一站式的医药定制研发和生产（CDMO）服务。公司的主要产品是小分子化学药物、多肽药物、偶联药物和小核酸药物。公司荣获2025中国医药CDMO企业20强、2024年度中国医药工业主营业务收入前100位企业、2024年EcoVadis企业社会责任评级“金牌”认证、全球优选合作伙伴奖、ESG责任企业奖等多项荣誉。","listedPrice":15.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九洲药业,603456,九洲药业股票,九洲药业股票老虎,九洲药业股票老虎国际,九洲药业行情,九洲药业股票行情,九洲药业股价,九洲药业股市,九洲药业股票价格,九洲药业股票交易,九洲药业股票购买,九洲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}